HomeFileCoronary disease

Coronary disease

View Category

Coronary disease

Aspirin, Clopidogrel and Warfarin. Is it safe or is a triple scheme necessary?

Original title: Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous...
solaci -
Learn More
Acute coronary syndromes

Improved efficacy and also increased bleeding with Rivaroxaban in Acute Myocardial Infarction

Original title: Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction. Results From the ATLAS ACS-2–TIMI-51 Trial....
solaci -
Learn More
Chronic Ischemic cardiopathy

Hybrid revascularization, combining strengths in high-risk patients

Original title: One-Stop Hybrid Coronary Revascularization versus Coronary Artery Bypass Graft and Percutaneous Coronary Intervention for the Treatment...
solaci -
Learn More
Chronic Ischemic cardiopathy

A real challenge: Primary PCI on an Unprotected Left Main Coronary Culprit Lesion

Original title: A Systematic Review and Meta-Analysis on Primary Percutaneous Coronary Intervention on an Unprotected Left Main Coronary...
solaci -
Learn More
Chronic Ischemic cardiopathy

The Instantaneous Wave-Free Ratio is Equivalent to Fractional Flow Reserve and does not require adenosine.

Original title: Diagnostic Classification of the Instantaneous Wave-Free Ratio Is Equivalent to Fractional Flow Reserve and Is Not...
solaci -
Learn More
Chronic Ischemic cardiopathy

Colchicine could reduce restenosis in diabetic patients treated with BMS

Original title: Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients. Reference: Spyridon Deftereos et al. J...
solaci -
Learn More
Acute coronary syndromes

First results of bioabsorbable metal scaffolds DREAMS

Original title: Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions:...
solaci -
Learn More
Coronary disease

5 Year Follow Up Outcome of Zotarolimus Eluting Stent

Original title: The "Final" 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting...
solaci -
Learn More